(Q24245451)

4

object named as

Jan Hendrik Richardus

0 references

author name string

Natasja HJ Van Veen

1

0 references

Peter G Nicholls

2

0 references

W Cairns S Smith

Cochrane Database of Systematic Reviews

3

0 references

publication date

18 April 2007

0 references

published in

0 references

cites work

Pure neural leprosy: steroids prevent neuropathy progression.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

Socioeconomics of a global leprosy eradication programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

The Participation Scale: measuring a key concept in public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

Decompressive surgery for treating nerve damage in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

The dynamics of stigma in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

A comparison of economic aspects of hospitalization versus ambulatory care in the management of neuritis occurring in lepra reaction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

Basic nerve function assessment in leprosy patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

The use of corticosteroids in leprosy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

The evaluation of nerve damage in leprosy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

The management of nerve damage in the leprosy control services

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

Treatment of leprous neuritis by neurolysis combined with perineural corticosteroid injection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

Reversal reactions in leprosy and their management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

Nerve function impairment in leprosy: an epidemiological and clinical study--Part 2: Results of steroid treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

The management of leprosy reversal reactions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

Reliability of Semmes Weinstein monofilament and ballpoint sensory testing, and voluntary muscle testing in Bangladesh

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

The treatment of acute nerve function impairment in leprosy: results from a prospective cohort study in Bangladesh

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021

The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005491.PUB2

7 January 2021